Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Research article

Epidemiological study of scarlet fever in Shenyang, China

Authors: Huijie Chen, Ye Chen, Baijun Sun, Lihai Wen, Xiangdong An

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Since 2011, there has been an increase in the incidence of scarlet fever across China. The main objective of this study was to depict the spatiotemporal epidemiological characteristics of the incidence of scarlet fever in Shenyang, China, in 2018 so as to provide the scientific basis for effective strategies of scarlet control and prevention.

Methods

Excel 2010 was used to demonstrate the temporal distribution at the month level and ArcGIS10.3 was used to demonstrate the spatial distribution at the district/county level. Moran’s autocorrelation coefficient was used to examine the spatial autocorrelation and the Getis-Ord statistic was used to determine the hot-spot areas of scarlet fever.

Results

A total of 2314 scarlet fever cases were reported in Shenyang in 2018 with an annual incidence of 31.24 per 100,000. The incidence among males was higher than that among females(p<0.001). A vast majority of the cases (96.89%) were among children aged 3 to 11 years. The highest incidence was 625.34/100,000 in children aged 5–9 years. In 2018 there were two seasonal peaks of scarlet fever in June (summer-peak) and December (winter-peak). The incidence of scarlet fever in urban areas was significantly higher than that in rural areas(p<0.001). The incidence of scarlet fever was randomly distributed in Shenyang. There are hotspot areas located in seven districts.

Conclusions

Urban areas are the hot spots of scarlet fever and joint prevention and control measures between districts should be applied. Children aged 3–11 are the main source of scarlet fever and therefore the introduction of prevention and control into kindergarten and primary schools may be key to the control of scarlet fever epidemics.
Literature
2.
go back to reference Dong H, Xu G, Li S, et al. Beta-haemolytic group a streptococci emm75 carrying altered pyrogenic exotoxin a linked to scarlet fever in adults. J Infect. 2008;56(4):261–7.CrossRef Dong H, Xu G, Li S, et al. Beta-haemolytic group a streptococci emm75 carrying altered pyrogenic exotoxin a linked to scarlet fever in adults. J Infect. 2008;56(4):261–7.CrossRef
3.
go back to reference Lau EHY, Hiroshi N, Cowling BJ, et al. Scarlet Fever Outbreak, Hong Kong,2011. Emerging Infectious Diseases. 2012;18(10):1700–2.CrossRef Lau EHY, Hiroshi N, Cowling BJ, et al. Scarlet Fever Outbreak, Hong Kong,2011. Emerging Infectious Diseases. 2012;18(10):1700–2.CrossRef
6.
go back to reference Kirby RS, Delmelle E, Eberth JM. Advances in spatial epidemiology and geographic information systems. Annals Epidemiol. 2017;27(1):1–9.CrossRef Kirby RS, Delmelle E, Eberth JM. Advances in spatial epidemiology and geographic information systems. Annals Epidemiol. 2017;27(1):1–9.CrossRef
7.
8.
go back to reference Tami A, Grillet ME, Grobusch MP. Applying geographical information systems (GIS) to arboviral disease surveillance and control: a powerful tool. Travel Med Infect Dis. 2016;14(1):9–10.CrossRef Tami A, Grillet ME, Grobusch MP. Applying geographical information systems (GIS) to arboviral disease surveillance and control: a powerful tool. Travel Med Infect Dis. 2016;14(1):9–10.CrossRef
9.
go back to reference Zhang Q, Liu W, Ma W, et al. Spatiotemporal epidemiology of scarlet fever in Jiangsu Province, China, 2005-2015. BMC Infect Dis. 2017;17(1):596–602.CrossRef Zhang Q, Liu W, Ma W, et al. Spatiotemporal epidemiology of scarlet fever in Jiangsu Province, China, 2005-2015. BMC Infect Dis. 2017;17(1):596–602.CrossRef
10.
go back to reference Gehendra M, Chao W, Da H, et al. Spatiotemporal pattern analysis of scarlet fever incidence in Beijing, China, 2005–2014. Int J Environ Res Public Health. 2016;13(1):131–48.CrossRef Gehendra M, Chao W, Da H, et al. Spatiotemporal pattern analysis of scarlet fever incidence in Beijing, China, 2005–2014. Int J Environ Res Public Health. 2016;13(1):131–48.CrossRef
11.
go back to reference Shao Q, Chen Y, Ying L. Epidemiological characteristics of scarlet fever in Shenyang from 2005 to 2012. J Strait Preventive Medicine. 2014;20(6):31–2. Shao Q, Chen Y, Ying L. Epidemiological characteristics of scarlet fever in Shenyang from 2005 to 2012. J Strait Preventive Medicine. 2014;20(6):31–2.
12.
go back to reference Yang X, Bai S. Epidemic trend analysis of scarlet fever in Shenyang from 2004 to 2009. Occupation health. 2011;27(4):439–41. Yang X, Bai S. Epidemic trend analysis of scarlet fever in Shenyang from 2004 to 2009. Occupation health. 2011;27(4):439–41.
13.
go back to reference Dai M. Epidemic characteristics of scarlet fever in Shenyang from 2004 to 2012. Occupation health. 2014;30(10):1361–2. Dai M. Epidemic characteristics of scarlet fever in Shenyang from 2004 to 2012. Occupation health. 2014;30(10):1361–2.
14.
go back to reference Dai M, Zhang C. Epidemiological characteristics of scarlet fever in Shenyang from 2013 to 2017. Forum Preventive Medicine. 2018;24(09):52–3. Dai M, Zhang C. Epidemiological characteristics of scarlet fever in Shenyang from 2013 to 2017. Forum Preventive Medicine. 2018;24(09):52–3.
19.
go back to reference Saxena R, Nagpal BN, Das MK, et al. A spatial statistical approach to analyze malaria situation at micro level for priority control in Ranchi district, Jharkhand [J]. Indian J Med Res. 2012;136(5):776–82.PubMedPubMedCentral Saxena R, Nagpal BN, Das MK, et al. A spatial statistical approach to analyze malaria situation at micro level for priority control in Ranchi district, Jharkhand [J]. Indian J Med Res. 2012;136(5):776–82.PubMedPubMedCentral
20.
go back to reference Liu Y, Chan TC, Yap LW, et al. Resurgence of scarlet fever in China: a 13-year population-based surveillance study. Lancet Infect Dis. 2018;8:903–12.CrossRef Liu Y, Chan TC, Yap LW, et al. Resurgence of scarlet fever in China: a 13-year population-based surveillance study. Lancet Infect Dis. 2018;8:903–12.CrossRef
21.
go back to reference Andrey DO, Posfay-Barbe KM. Re-emergence of scarlet fever: old players return. Expert Rev Anti-Infect Ther. 2014;8:687–9. Andrey DO, Posfay-Barbe KM. Re-emergence of scarlet fever: old players return. Expert Rev Anti-Infect Ther. 2014;8:687–9.
22.
go back to reference Luk EY, Lo JY, Li AZ, et al. Scarlet fever epidemic, Hong Kong, 2011. Emerg Infect Dis. 2012(10):1658–61. Luk EY, Lo JY, Li AZ, et al. Scarlet fever epidemic, Hong Kong, 2011. Emerg Infect Dis. 2012(10):1658–61.
23.
go back to reference Kim JH, Cheong HK. Increasing number of scarlet fever cases, South Korea, 2011-2016. Emerg Infect Dis. 2018;24(1):172–3.CrossRef Kim JH, Cheong HK. Increasing number of scarlet fever cases, South Korea, 2011-2016. Emerg Infect Dis. 2018;24(1):172–3.CrossRef
24.
go back to reference Brockmann SO, Eichner L, Eichner M. Constantly high incidence of scarlet fever in Germany. Lancet Infect Dis. 2018;5:499–500.CrossRef Brockmann SO, Eichner L, Eichner M. Constantly high incidence of scarlet fever in Germany. Lancet Infect Dis. 2018;5:499–500.CrossRef
25.
go back to reference Lamagni T, Guy R, Chand M, et al. Resurgence of scarlet fever in England, 2014-2016 A population-based surveillance study. Lancet Infect Dis. 2018(2):180–7.CrossRef Lamagni T, Guy R, Chand M, et al. Resurgence of scarlet fever in England, 2014-2016 A population-based surveillance study. Lancet Infect Dis. 2018(2):180–7.CrossRef
26.
go back to reference Mahara G, Chhetri JK, Guo X, et al. Increasing prevalence of scarlet fever in China. BMJ. 2016;353:i2689.CrossRef Mahara G, Chhetri JK, Guo X, et al. Increasing prevalence of scarlet fever in China. BMJ. 2016;353:i2689.CrossRef
27.
go back to reference Choi JH, Yang NR, Lee WJ, et al. Distribution of emm types among group a streptococcus isolates from children in Korea. Diagnostic Microbiol Infect Dis. 2015;82(1):26–31.CrossRef Choi JH, Yang NR, Lee WJ, et al. Distribution of emm types among group a streptococcus isolates from children in Korea. Diagnostic Microbiol Infect Dis. 2015;82(1):26–31.CrossRef
28.
go back to reference Turner CE, Pyzio M, Song B, et al. Scarlet fever upsurge in England and molecular-genetic analysis in north-West London, 2014. Emerg Infect Dis. 2016;22(6):1075–8.CrossRef Turner CE, Pyzio M, Song B, et al. Scarlet fever upsurge in England and molecular-genetic analysis in north-West London, 2014. Emerg Infect Dis. 2016;22(6):1075–8.CrossRef
29.
go back to reference Guy R, Williams C, Irvine N, et al. Increase in scarlet fever notifications in the United Kingdom, 2013/2014. Euro Surveill. 2014;19(12):20749.CrossRef Guy R, Williams C, Irvine N, et al. Increase in scarlet fever notifications in the United Kingdom, 2013/2014. Euro Surveill. 2014;19(12):20749.CrossRef
30.
go back to reference Zhang T, Yin F, Zhou T, et al. Multivariate time series analysis on the dynamic relationship between class B notifiable diseases and gross domestic product (GDP) in China [J]. Sci Rep. 2016;6(1):29.CrossRef Zhang T, Yin F, Zhou T, et al. Multivariate time series analysis on the dynamic relationship between class B notifiable diseases and gross domestic product (GDP) in China [J]. Sci Rep. 2016;6(1):29.CrossRef
31.
go back to reference Wang Y, Xu C, Wang Z, et al. Seasonality and trend prediction of scarlet fever incidence in mainland China from 2004 to 2018 using a hybrid SARIMA-NARX model. PeerJ,2019,7:e6165. Wang Y, Xu C, Wang Z, et al. Seasonality and trend prediction of scarlet fever incidence in mainland China from 2004 to 2018 using a hybrid SARIMA-NARX model. PeerJ,2019,7:e6165.
32.
go back to reference You Y, Davies MR, Protani M, et al. Scarlet Fever Epidemic in China Caused by Streptococcus pyogenes Serotype M12: Epidemiologic and Molecular Analysis. EBioMedicine. 2018;28(C):128–35.CrossRef You Y, Davies MR, Protani M, et al. Scarlet Fever Epidemic in China Caused by Streptococcus pyogenes Serotype M12: Epidemiologic and Molecular Analysis. EBioMedicine. 2018;28(C):128–35.CrossRef
33.
go back to reference Wu SS, Ma CN, Peng XM, et al. Characteristics on the onset features of scarlet fever in Beijing,2006–2015. J epidemiology. 2017;38(4):514–7. Wu SS, Ma CN, Peng XM, et al. Characteristics on the onset features of scarlet fever in Beijing,2006–2015. J epidemiology. 2017;38(4):514–7.
34.
go back to reference Gehendra M, Chao W, Kun Y, et al. The association between environmental factors and scarlet fever incidence in Beijing region: using GIS and spatial regression models [J]. Int J Environ Res Public Health. 2016;13(11):1083–98.CrossRef Gehendra M, Chao W, Kun Y, et al. The association between environmental factors and scarlet fever incidence in Beijing region: using GIS and spatial regression models [J]. Int J Environ Res Public Health. 2016;13(11):1083–98.CrossRef
37.
go back to reference Wong SS, Yuen KY. Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerging Microbes Infections. 2012;1(7):e2.PubMedPubMedCentral Wong SS, Yuen KY. Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerging Microbes Infections. 2012;1(7):e2.PubMedPubMedCentral
Metadata
Title
Epidemiological study of scarlet fever in Shenyang, China
Authors
Huijie Chen
Ye Chen
Baijun Sun
Lihai Wen
Xiangdong An
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4705-9

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.